Pfizer 4Q Revenues: $15.1 billion (-7%) 4Q Earnings: $6.3 billion (earnings were $1.4 billion in 4Q11) YTD Revenues: $59.0 billion (-10%) YTD Earnings: $14.6 billion (+46%) Comments: U.S. revenues were $5.8 billion in the quarter, down 9% primarily due to the loss of exclusivity of Lipitor (-79% to $584 million) in November 2011 and Geodon in March 2012. International revenues were $9.3 billion, down 5% due to the losses for Lipitor in Europe in 2Q12 and the unfavorable impact of foreign ex...